Certain statements in this report may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Accordingly, stockholders should not assume that we agree with any statement or report issued by any analyst irrespective of the content of the statement or report.
Business Overview – a brief synopsis of our Company for the periods ended August 31, 2019 and September 1, 2018.
Liquidity, Financial Position and Capital Resources – a discussion of our primary sources and uses of cash for the three month periods ended August 31, 2019 and September 1, 2018, and a discussion of changes in our financial position.
Richardson Electronics, Ltd. is a leading global provider of engineered solutions, power grid and microwave tubes and related consumables; power conversion and RF and microwave components; high value flat panel detector solutions, replacement parts, tubes and service training for diagnostic imaging equipment; and customized display solutions.
The Company’s strategy is to provide specialized technical expertise and “engineered solutions” based on our core engineering and manufacturing capabilities.
The Company provides solutions and adds value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair through its global infrastructure.
These products are used to control, switch or amplify electrical power signals, or are used as display devices in a variety of industrial, commercial, medical and communication applications.
As a manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis.
We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure.
PMT’s focus is on products for power, RF and microwave applications for customers in 5G, alternative energy, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets.
PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology.
PMT also offers its customers technical services for both microwave and industrial equipment.
Canvys provides customized display solutions serving the corporate enterprise, financial, healthcare, industrial and medical original equipment manufacturers markets.
Our engineers design, manufacture, source and support a full spectrum of solutions to match the needs of our customers.
We offer long term availability and proven custom display solutions that include touch screens, protective panels, custom enclosures, all-in-ones, specialized cabinet finishes and application specific software packages and certification services.
Our volume commitments are lower than the large display manufacturers, making us the ideal choice for companies with very specific design requirements.
Healthcare manufactures, refurbishes and distributes high value replacement parts for the healthcare market including hospitals, medical centers, asset management companies, independent service organizations and multi-vendor service providers.
Products include Diagnostic Imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; and additional replacement solutions currently under development for the diagnostic imaging service market.
Through a combination of newly developed products and partnerships, service offerings and training programs, we believe we can help our customers improve efficiency and deliver better clinical outcomes while lowering the cost of healthcare delivery.
Net sales during the first quarter of fiscal 2020 were $40.7 million, a decrease of 7.9%, compared to net sales of $44.2 million during the first quarter of fiscal 2019.
Gross margin increased to 31.9% during the first quarter of fiscal 2020 compared to 31.6% during the first quarter of fiscal 2019.
Selling, general and administrative expenses were $12.8 million, or 31.6% of net sales, during the first quarter of fiscal 2020 compared to $13.1 million, or 29.7% of net sales, during the first quarter of fiscal 2019.
Operating income during the first quarter of fiscal 2020 was $0.1 million compared to an operating income of $0.9 million during the first quarter of fiscal 2019.
During the first quarter of fiscal 2020, consolidated net sales decreased 7.9% compared to the first quarter of fiscal 2019.
Sales for PMT decreased 12.1%, sales for Canvys increased 1.4% and sales for Healthcare increased 26.8%.
The decrease in PMT was mainly due to a continued slowdown in the wafer fab equipment market, slightly offset by growth from our power conversion and RF and microwave components.
The increase in Canvys was due to increased customer demand in its North American market.
The increase in Healthcare was due to higher CT tube and parts sales.
Consolidated gross margin as a percentage of net sales increased to 31.9% during the first quarter of fiscal 2020 from 31.6% during the first quarter of fiscal 2019, primarily due to favorable product mix and manufacturing over absorption for Healthcare somewhat offset by unfavorable product mix and unfavorable foreign exchange rates for Canvys.
PMT net sales decreased 12.1% to $30.6 million during the first quarter of fiscal 2020 from $34.8 million during the first quarter of fiscal 2019.
The decrease was mainly due to a decline in the wafer fab equipment market, slightly offset by growth from our power conversion and RF and microwave components.
Gross margin as a percentage of net sales was 31.7% during the first quarter of fiscal 2020, the same as 31.7% during the first quarter of fiscal 2019.
Canvys net sales increased 1.4% to $7.3 million during the first quarter of fiscal 2020 from $7.2 million during the first quarter of fiscal 2019 due to increased customer demand in its North American market.
Gross margin as a percentage of net sales decreased to 31.9% during the first quarter of fiscal 2020 as compared to 32.2% during the first quarter of fiscal 2019, due to unfavorable product mix and foreign exchange.
Healthcare net sales increased 26.8% to $2.8 million during the first quarter of fiscal 2020 from $2.2 million during the first quarter of fiscal 2019 due to higher CT tube and parts sales.
Selling, general and administrative expenses decreased to $12.8 million during the first quarter of fiscal 2020 from $13.1 million in the first quarter of fiscal 2019, primarily due to lower employee benefits, IT and bad debt expenses.
We recorded an income tax provision of $0.2 million and $0.3 million for the first three months of fiscal 2020 and the first three months of fiscal 2019, respectively.
The effective income tax rate during the first three months of fiscal 2020 was a tax provision of 53.0% as compared to a tax provision of 38.6% during the first three months of fiscal 2019.
The difference in rate during the first three months of fiscal 2020 as compared to the first three months of fiscal 2019 reflects changes in our geographical distribution of income (loss).
Our operations and cash needs have been primarily financed through income from operations and cash on hand.
We believe that the existing sources of liquidity, including current cash, will provide sufficient resources to meet known capital requirements and working capital needs through the next twelve months.
Operating activities used $2.1 million of cash during the first three months of fiscal 2020.
We had net income of $0.2 million during the first three months of fiscal 2020, which included non-cash stock-based compensation expense of $0.2 million associated with the issuance of stock option and restricted stock awards, $0.2 million for inventory reserve provisions and depreciation and amortization expense of $0.8 million associated with our property and equipment as well as amortization of our intangible assets.
Changes in our operating assets and liabilities resulted in a use of cash of $3.3 million during the first three months of fiscal 2020, net of foreign currency exchange gains and losses, included a decrease of $4.0 million in accounts payable, an increase in inventory of $1.4 million, a decrease in accrued liabilities of $0.9 million partially offset by a decrease in accounts receivable of $2.2 million and a decrease of $0.6 million in prepaid expenses and other assets.
We had net income of $0.4 million during the first three months of fiscal 2019, which included non-cash stock-based compensation expense of $0.2 million associated with the issuance of stock option and restricted stock awards, $0.2 million for inventory reserve provisions and depreciation and amortization expense of $0.8 million associated with our property and equipment as well as amortization of our intangible assets.
Changes in our operating assets and liabilities resulted in a use of cash of $5.3 million during the first three months of fiscal 2019, net of foreign currency exchange gains and losses, included a decrease of $5.4 million in accounts payable and an increase in accounts receivable of $0.2 million, partially offset by an increase in accrued liabilities of $0.2 million.
The cash flow provided by and used in investing activities consisted primarily of proceeds from the maturities of investments and capital expenditures.
Cash provided by investing activities of $7.7 million during the first three months of fiscal 2020 included proceeds from the maturities of investments of $8.0 million partially offset by $0.3 million in capital expenditures.
Capital expenditures related primarily to capital used for our IT system and LaFox manufacturing business.
Cash used in investing activities of $3.4 million during the first three months of fiscal 2019 included $2.3 million from purchases of investments and $1.1 million in capital expenditures.
Capital expenditures related primarily to our Healthcare growth initiatives, a new air conditioner unit for the building and capital used for our IT system.
Our purchases of investments consisted of CDs.
All future payments of dividends are at the discretion of the Board of Directors.
Dividend payments will depend on earnings, capital requirements, operating conditions and such other factors that the Board may deem relevant.
We held our annual meeting of stockholders on October 8, 2019.
At the annual meeting, our stockholders (i) elected each of the nominees listed below to the Company's Board of Directors to serve for a term expiring at the 2020 Annual Meeting; (ii) ratified the selection of BDO USA, LLP as our independent registered public accounting firm for fiscal year 2020, and (iii) approved, on an advisory basis, the compensation of the Company's named executive officers.
The final results for the votes regarding each proposal are set forth below.
